Indapamide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for indapamide and what is the scope of freedom to operate?

Indapamide is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Ani Pharms, Aurobindo Pharma Usa, Chartwell Rx, Rising, Teva, Watson Labs, and Sanofi Aventis Us, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for indapamide. Six suppliers are listed for this compound.

Sponsor	Phase
Centre for Chronic Disease Control, India	Phase 4
All India Institute of Medical Sciences, New Delhi	Phase 4
The Third Xiangya Hospital of Central South University	Phase 4

Sponsor

Phase

Centre for Chronic Disease Control, India

Phase 4

All India Institute of Medical Sciences, New Delhi

Phase 4

The Third Xiangya Hospital of Central South University

Phase 4

US Patents and Regulatory Information for indapamide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	INDAPAMIDE	indapamide	TABLET;ORAL	075201-002	Dec 4, 1998		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Actavis Elizabeth	INDAPAMIDE	indapamide	TABLET;ORAL	074722-001	Jun 17, 1996	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva	INDAPAMIDE	indapamide	TABLET;ORAL	074665-001	Apr 4, 1997		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ani Pharms	INDAPAMIDE	indapamide	TABLET;ORAL	074498-001	Oct 31, 1996		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma Usa	INDAPAMIDE	indapamide	TABLET;ORAL	075105-001	Jul 23, 1998		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma Usa	INDAPAMIDE	indapamide	TABLET;ORAL	075105-002	Jul 23, 1998		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	LOZOL	indapamide	TABLET;ORAL	018538-001	Jul 6, 1983	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

TABLET;ORAL

Jul 6, 1983

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Try a Trial

US Patents:	0
Tradenames:	2
Applicants:	8
NDAs:	10
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	114
Clinical Trials:	31
Patent Applications:	6,601
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for indapamide
What excipients (inactive ingredients) are in indapamide?	indapamide excipients list
DailyMed Link:	indapamide at DailyMed

Drug Class	Thiazide-like Diuretic
Physiological Effect	Increased Diuresis

Indapamide - Generic Drug Details

What are the generic drug sources for indapamide and what is the scope of freedom to operate?

Summary for indapamide

Recent Clinical Trials for indapamide

Pharmacology for indapamide

Medical Subject Heading (MeSH) Categories for indapamide

US Patents and Regulatory Information for indapamide

Expired US Patents for indapamide

Make Better Decisions: Try a trial or see plans & pricing